AzTrials
AzTrials

Pediatric CancerNCT05639062

Narrative-based Card Game in Improving Spiritual Well-being Among Chinese Childhood Cancer Patients

A study testing Narrative-based card game in people with Pediatric Cancer, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Cancer as a life-threatening disease can trigger children's unique spiritual needs. Unmet spiritual needs can cause low level of spiritual well-being, which is a central component for the overall quality of life (QoL) of cancer patients and was inversely associated with depressive symptoms, anxiety and a low level of… Read more about this study

Who is it for?
Ages 12 to 17 years
Conditions the study is for
Pediatric Cancer
What is being tested?
Narrative-based card game
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteHong Kong
Study dates
1 Jan 2023to 1 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Inclusion Criteria: (1) age 12-17 old (2) diagnosed with any type of cancer and currently undergoing active treatment (3) knowing about their cancer diagnosis, and (4) able to communicate with Chinese.

-

Exclusion Criteria: (1) those with identified cognitive and/or behavioural problems which affected their verbal communication; (2) those with advanced cancer, including nonresponsive to treatment, stage IV solid tumor that had recurred or progressed as defined, or physician estimated poor prognosis of <60%.

-

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Hong Kong Polytechnic University

    Hong Kong, 0000

Other trials in Hong Kong

About this study

Official title: Narrative-based Card Game (NCG) in Improving Spiritual Well-being, Enhancing Hope, Decreasing Psychological Symptoms, and Promoting Quality of Life Among Chinese Childhood Cancer Patients: A Pilot Randomized Controlled Trial

Cancer as a life-threatening disease can trigger children's unique spiritual needs. Unmet spiritual needs can cause low level of spiritual well-being, which is a central component for the overall quality of life (QoL) of cancer patients and was inversely associated with depressive symptoms, anxiety and a low level of hope. However, there has been no intervention focused on improving spiritual well-being among childhood cancer patients. Evidence from adult cancer patients suggests that narrative intervention can effectively address spiritual needs and improve spiritual well-being, while playing card game can combine an emotionally sensitive topic with an enjoyable activity, providing insight into the development of narrative-based card games for childhood cancer patients. The first objective of this pilot study is to assess the feasibility of narrative-based card game among Chinese childhood cancer patients. The second objective is to evaluate the preliminary effects of narrative-based card game intervention on spiritual well-being, hope, anxiety, depressive symptoms, and QoL of childhood cancer patients at postintervention and at 1-, and 3-month follow-up postintervention.

Read the detailed description

A pilot randomized controlled trial will be carried out. A convenience sample of 60 children with cancer will be recruited. Subjects who are randomized into the experimental group which will participate the narrative-based card game or into the control group which will play a PUKE card game only for entertainment purpose, that mimics the time and attention of the intervention. Feasibility measures (i.e., the eligibility rate, consent rate, randomization rate etc.) will be collected immediately after the completion of the intervention. Also, all subjects will be asked to complete structured questionnaires to assess their spiritual well-being, hope, anxiety, depressive symptoms, and QoL at postintervention and at 1-, and 3-month follow-up postintervention.

Being tested
Narrative-based card game
Keywords
spiritual well-being, intervention, childhood cancer patients
Medical subject headings
Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Narrative-based card gameBehavioural

    This intervention aims to evaluate the preliminary effects of narrative-based card game intervention on spiritual well-being, hope, anxiety, depressive symptoms, and QoL of childhood cancer patients at postintervention and at 1-, and 3-month follow-up postintervention.

Study groups in NCT05639062
Study groupRoleWhat they receive
Narrative-based card gameActive comparatorNot described
Receives: Behavioral: Narrative-based card game
PUKE card gameNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The length of recruitment

    The time used for subject recruitment

    Measured: baseline

  2. Eligibility rate

    The number of eligible childhood cancer patients divided by the number of childhood cancer patients screened prior to eligibility assessment

    Measured: baseline

  3. Consent rate

    The number of eligible childhood cancer patients who agree to participate divided by the number of eligible childhood cancer patients

    Measured: baseline

  4. Randomization rate

    The number of participants who are randomized divided by the number of consenting children

    Measured: baseline

  5. Attendance rate

    The number of participants in the experimental group who complete the intervention divided by the number of participants randomized into the group

    Measured: post-intervention

  6. Retention rate

    The number of participants who remain in the study divided by the number of participants randomized. Retention rate will be calculated at baseline and follow ups.

    Measured: post-intervention, and 1-month, 3- month follow ups

  7. Completion rate

    The number of participants who complete the questionnaire divided by the number of questionnaires distributed.

    Measured: post-intervention, and 1-month, 3-month follow ups

  8. Missing data

    The percentage of missing data.

    Measured: post-intervention, 1-month, 3- month follow ups

  9. Adverse events

    Unfavorable or unintended events during the study period that were not present at baseline or appear to have worsened since baseline.

    Measured: post-intervention, 1-month, 3-month follow ups

Secondary outcomes (1)
  1. The Chinese version of adapted Functional Assessment of Chronic Illness Therapy Spiritual Well-being Scale at 3 months follow-up

    Assessing the spiritual well-being of participants, the score for the Chinese version of adapted Functional Assessment of Chronic Illness Therapy Spiritual Well-being Scale is 0-60, with higher scaores indicating higher spiritual well-being

    Measured: at 3-months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2022
  2. Study start1 Jan 2023 (estimated)
  3. Primary completion1 Oct 2023 (estimated)
  4. Study completion1 Jan 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05639062
Sponsor's protocol ID
NCG
Status last verified
Nov 2022
First submitted
7 Nov 2022
Last updated
6 Dec 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Liu Q, Ho KY, Lam KKW, Wong FKY, Lam W, Cheng F, Wei H, Chan K, Ting M, Yang FN, Xiao P, Luo T, Wang HX, Yorke J. Preliminary effectiveness and feasibility of an integrated hope techniques and narrative-based card game intervention for pediatric cancer patients in China: a randomized controlled trial. BMC Med. 2025 Jul 31;23(1):449. doi: 10.1186/s12916-025-04287-5.

    PubMed 40745312

Questions about this trial

What is this clinical trial studying?

A study testing Narrative-based card game in people with Pediatric Cancer, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The length of recruitment (time frame: baseline). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05639062, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in